Sign In
Buy TMDX
$71.37
+1.68 (+2.41%)
At Close: Jun 04, 2026
TransMedics Group, Inc. Investigated Regarding Potential Securities Law Violations - Contact Levi & Korsinsky for Details - TMDX
07:30am, Thursday, 31'st Oct 2024
NEW YORK, NY / ACCESSWIRE / October 31, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of TransMedics Group, Inc. ("TransMedics Group, Inc.") (NASDAQ:TMDX) concernin
SAN DIEGO--(BUSINESS WIRE)--Robbins Geller Rudman & Dowd LLP is investigating potential violations of U.S. federal securities laws involving TransMedics Group, Inc. (NASDAQ: TMDX) focused on whether t
TransMedics (TMDX) Reports Q3 Earnings: What Key Metrics Have to Say
10:35am, Wednesday, 30'th Oct 2024
Although the revenue and EPS for TransMedics (TMDX) give a sense of how its business performed in the quarter ended September 2024, it might be worth considering how some key metrics compare with Wall
TransMedics: Maintaining A Neutral Stance After A Difficult Q3
09:07am, Wednesday, 30'th Oct 2024
TMDX which was outperforming the S&P500 by 6x in August, is now only generating half the returns of the benchmark on a YTD basis. The Q3 event appears to have spooked investors and we dive in to cover
TransMedics Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
04:05pm, Tuesday, 29'th Oct 2024
ANDOVER, Mass. , Oct. 29, 2024 /PRNewswire/ -- TransMedics Group, Inc. ("TransMedics") (Nasdaq: TMDX), a medical technology company that is transforming organ transplant therapy for patients with end-
TransMedics: Every Hero Becomes A Bore At Last
03:23pm, Tuesday, 29'th Oct 2024
TransMedics Group, Inc. faces significant challenges due to aircraft maintenance issues and rising aviation costs, leading to a 42% stock price drop and a HOLD rating. Revenue shortfall is attributed
TransMedics Stock Falls as Q3 Earnings & Sales Miss Estimates
11:25am, Tuesday, 29'th Oct 2024
TMDX's third-quarter revenues increase with the utilization of the OCS across all three organs and additional revenues generated by its logistics services. Gross margin contracts.
Did TransMedics Group, Inc. Mislead Investors? Shareholder Rights Advocates at Levi & Korsinsky Investigate - TMDX
11:15am, Tuesday, 29'th Oct 2024
NEW YORK, NY / ACCESSWIRE / October 29, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of TransMedics Group, Inc. ("TransMedics Group, Inc.") (NASDAQ:TMDX) concernin
TransMedics: Mistakes Have Been Made, Here's My Updated Outlook
10:18am, Tuesday, 29'th Oct 2024
TransMedics shares fell 25% pre-market after a disappointing Q3 report, missing revenue and EPS estimates, with management failing to manage expectations. Despite the poor quarter, the long-term oppor
These Analysts Cut Their Forecasts On TransMedics Group Following Weak Results
09:15am, Tuesday, 29'th Oct 2024
TransMedics Group, Inc. TMDX posted downbeat quarterly results on Monday.
TransMedics Stock Crashes After Earnings Disappointment. Time to Load Up the Boat?
09:02am, Tuesday, 29'th Oct 2024
Is this the buy-the-dip opportunity investors have been waiting for?
U.S. stock futures were mixed this morning, with the Dow futures falling around 50 points on Tuesday.
SAN DIEGO, Oct. 28, 2024 (GLOBE NEWSWIRE) -- DiCello Levitt LLP announces that it is investigating whether TransMedics Group, Inc. (“TransMedics” or the “Company”) (NASDAQ:TMDX) complied with
TransMedics Group, Inc. (TMDX) Q3 2024 Earnings Call Transcript
07:25pm, Monday, 28'th Oct 2024
TransMedics Group, Inc. (NASDAQ:TMDX ) Q3 2024 Earnings Conference Call October 28, 2024 4:30 PM ET Company Participants Laine Morgan - Gilmartin Group, Investor Relations Waleed Hassanein - President
TransMedics (TMDX) Q3 Earnings and Revenues Miss Estimates
06:31pm, Monday, 28'th Oct 2024
TransMedics (TMDX) came out with quarterly earnings of $0.12 per share, missing the Zacks Consensus Estimate of $0.28 per share. This compares to loss of $0.12 per share a year ago.
